CRP, IL-6 and the Anti-Inflammatory Case for Keto
Chronic low-grade inflammation underpins many modern health conditions, from heart disease to type 2 diabetes. The ketogenic diet shows promise in reducing inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6), according to peer-reviewed studies. This matters because CRP levels above 3 mg/L indicate elevated cardiovascular risk, while IL-6 promotes insulin resistance.
How Keto Affects Inflammatory Markers
Carbohydrate restriction appears to lower inflammation through multiple pathways. A 2018 study found CRP reductions of 39% in people with type 2 diabetes after one year on a ketogenic diet (Hallberg et al., 2018). The mechanism likely involves reduced oxidative stress when the body switches from glucose to ketones for fuel. Fewer blood glucose spikes mean fewer reactive oxygen species damaging tissues.
Fat adaptation also decreases IL-6 production in adipose tissue. This cytokine drives systemic inflammation and is elevated in people living with obesity. the keto adaptation timeline typically shows IL-6 reductions within 8-12 weeks as insulin sensitivity improves.
What This Means in Practice
Supermarkets like Tesco now stock keto-friendly staples like almond flour (£3.20 for 200g) and coconut oil, making the diet accessible year-round. During British winter months when vitamin D levels drop—a known inflammatory trigger—keto’s emphasis on fatty fish provides anti-inflammatory omega-3s. The NHS recognises diet as a first-line intervention for metabolic conditions linked to inflammation.
Cardiovascular and Metabolic Benefits
Research associates lower CRP with improved lipid profiles. A 2019 analysis found triglyceride reductions of 24% alongside CRP drops in ketogenic diet groups (Hyde et al., 2019). This dual effect suggests keto may benefit those with metabolic syndrome beyond weight loss alone. common keto electrolyte mistakes can initially mask these benefits if sodium intake is inadequate.
Frequently Asked Questions
Does keto reduce inflammation in everyone? Individual responses vary based on genetics and baseline health. Those with autoimmune conditions sometimes report symptom improvement, but clinical evidence remains limited outside metabolic disorders.
How long until CRP levels drop? Most studies show significant reductions within 3-6 months. Faster improvements occur in people with higher starting CRP levels.
Are there risks to very low CRP? CRP below 1 mg/L is physiologically normal. Only extremely low levels (seen in rare genetic conditions) impair infection response.
The Bottom Line
The ketogenic diet demonstrates consistent anti-inflammatory effects in clinical trials, particularly for CRP and IL-6 markers tied to metabolic disease. While not a universal solution, it offers a dietary approach to modulating chronic inflammation without pharmaceuticals. If you’d rather not do the macro maths yourself, the Keto Dieting app does it for you on Google Play and the App Store.
References
- Hallberg SJ, McKenzie AL, Williams PT, et al. (2018). Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Therapy. https://doi.org/10.1007/s13300-018-0373-9
- Hyde PN, Sapper TN, Crabtree CD, et al. (2019). Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. JCI Insight. https://doi.org/10.1172/jci.insight.128308

